Moderna says FDA needs more time to review its Covid vaccine for 12-17
#1

The agency is looking specifically at the risk of myocarditis in kids, Moderna said in a statement Sunday, and the review may not be completed before January 2022. Myocarditis is the inflammation of the heart muscle.


https://www.cnbc.com/2021/10/31/covid-mo...teens.html
Reply


Forum Jump:


Users browsing this thread: 1 Guest(s)